Carboplatin
CAS No. 41575-94-4
Carboplatin ( —— )
Catalog No. M14423 CAS No. 41575-94-4
A chemotherapy agent that interferes with DNA replication and kills cancer cells; induces growth arrest and/or apoptosis in most cancer cell types; an alkylating agent for treatment of a number of cancers.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
Size | Price / USD | Stock | Quantity |
50MG | 32 | In Stock |
|
100MG | 43 | In Stock |
|
200MG | 60 | In Stock |
|
500MG | 103 | In Stock |
|
1G | Get Quote | In Stock |
|
Biological Information
-
Product NameCarboplatin
-
NoteResearch use only, not for human use.
-
Brief DescriptionA chemotherapy agent that interferes with DNA replication and kills cancer cells; induces growth arrest and/or apoptosis in most cancer cell types; an alkylating agent for treatment of a number of cancers.
-
DescriptionA chemotherapy agent that interferes with DNA replication and kills cancer cells; induces growth arrest and/or apoptosis in most cancer cell types; an alkylating agent for treatment of a number of cancers. Chemotherapeutic Agents Approved
-
Synonyms——
-
PathwayCell Cycle/DNA Damage
-
TargetDNA Alkylator
-
RecptorDNAsynthesis
-
Research AreaCancer
-
IndicationChemotherapeutic
Chemical Information
-
CAS Number41575-94-4
-
Formula Weight371.25
-
Molecular FormulaC6H12N2O4Pt
-
Purity>98% (HPLC)
-
SolubilityH2O: 6.6 mg/mL (Need warming); DMSO: < 6.8 mg/mL
-
SMILES[O-]C(C1(CCC1)C([O-])=O)=O.[Pt+2].N.N
-
Chemical NamePlatinum, diammine[1,1-cyclobutanedicarboxylato(2-)-κO,κO'']-, (SP-4-2)-
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
molnova catalog
related products
-
Evofosfamide
A potent and selective hypoxia-activated phosphoramidate DNA cross-linking mustard; selectively potent under hypoxia and stable to liver microsomes.
-
CM03
CM03 is a G-quadruplex-binding compound that potently inhibits cell growth in PDAC cell lines (MIA PaCa-2 IC50=19 nM).
-
Methyl methanesulfon...
Methyl methanesulfonate is a DNA alkylator that modifies adenine (3-methyladenine) and guanine (7-methyladenine) respectively, resulting in base mismatch and replication disorders.